Nyxoah S.A. (NASDAQ:NYXH – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 59,800 shares, a drop of 77.3% from the April 30th total of 263,200 shares. Currently, 0.6% of the shares of the company are short sold. Based on […]
StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. A number of other research firms also recently issued reports on CRBP. Jefferies Financial Group raised shares of Corbus Pharmaceuticals from a hold rating to a buy rating […]
StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Other research analysts have also recently issued reports about the company. Oppenheimer boosted their price target on Corbus Pharmaceuticals from $58.00 to $60.00 and gave the stock an outperform rating […]
JMP Securities reissued their market outperform rating on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $48.00 target price on the stock. Several other equities analysts have also issued reports on the company. HC Wainwright reaffirmed a buy rating […]
BiomX Inc. (NYSEMKT:PHGE – Free Report) – Analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of BiomX in a research note issued on Tuesday, May 21st. HC Wainwright analyst J. Pantginis now expects that the company will post earnings per share of ($0.12) for the quarter, down from their previous estimate […]